Interpretation of NT-proBNP in specific patient populations
Glasgow, United Kingdom, 10-May-05
Collinson, Dr. P. O., London, United Kingdom
General and specific aspects of NTproBNP in the clinical and laboratory setting – introduction
Christenson, Dr. R. H., Maryland, United States
Clinical utility of N-terminal pro B-type natriuretic peptide in patients with heart failure and acute coronary syndrome
Emdin, Dr. M., Pisa, Italy
NT-proBNP vs. BNP for the detection of early / mild forms of heart failure